Sugammadex-associated asystole in young obese patient: Case report

Sugammadex is a neuromuscular blocking (NMB) reversal agent that has quickly become popular among anesthesia providers since its FDA approval in 2015 due to its favorable properties. There are rare but significant and increasingly reported adverse cardiac events, including symptomatic bradycardia, a...

Full description

Bibliographic Details
Main Authors: Steven J. Lohmeier, David B. Powers
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Oral and Maxillofacial Surgery Cases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221454192200030X
_version_ 1818516369332764672
author Steven J. Lohmeier
David B. Powers
author_facet Steven J. Lohmeier
David B. Powers
author_sort Steven J. Lohmeier
collection DOAJ
description Sugammadex is a neuromuscular blocking (NMB) reversal agent that has quickly become popular among anesthesia providers since its FDA approval in 2015 due to its favorable properties. There are rare but significant and increasingly reported adverse cardiac events, including symptomatic bradycardia, asystole, cardiac arrest, and death. Since its introduction into the United States (US) market, there have been ten reported cases of asystole and cardiac arrest within minutes of sugammadex administration. Some incidents required cardiopulmonary resuscitation (CPR) and prolonged treatment in the Intensive Care Unit (ICU) for successful management. We present the youngest known case of sugammadex-associated asystole in a non-cardiac patient. Further investigation is warranted to understand better both the patient-related factors and drug administration techniques involved in Sugammadex-associated cardiovascular compromise to improve clinical decision-making for anesthesia providers.
first_indexed 2024-12-11T00:41:08Z
format Article
id doaj.art-864a3e250ea148368a78474b31f66f4d
institution Directory Open Access Journal
issn 2214-5419
language English
last_indexed 2024-12-11T00:41:08Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Oral and Maxillofacial Surgery Cases
spelling doaj.art-864a3e250ea148368a78474b31f66f4d2022-12-22T01:26:55ZengElsevierOral and Maxillofacial Surgery Cases2214-54192022-09-0183100271Sugammadex-associated asystole in young obese patient: Case reportSteven J. Lohmeier0David B. Powers1Division of Plastic, Maxillofacial & Oral Surgery, Duke University Hospital, Durham, NC, USA; US Air Force Dental Corps, USADivision of Plastic, Maxillofacial & Oral Surgery, Duke University Hospital, Durham, NC, USA; Corresponding author. Division of Plastic, Maxillofacial & Oral Surgery, Duke University Hospital, DUMC 3974 — Room 110 Baker House, 200 Trent Drive at Erwin Road, Durham, NC, 27710, USA.Sugammadex is a neuromuscular blocking (NMB) reversal agent that has quickly become popular among anesthesia providers since its FDA approval in 2015 due to its favorable properties. There are rare but significant and increasingly reported adverse cardiac events, including symptomatic bradycardia, asystole, cardiac arrest, and death. Since its introduction into the United States (US) market, there have been ten reported cases of asystole and cardiac arrest within minutes of sugammadex administration. Some incidents required cardiopulmonary resuscitation (CPR) and prolonged treatment in the Intensive Care Unit (ICU) for successful management. We present the youngest known case of sugammadex-associated asystole in a non-cardiac patient. Further investigation is warranted to understand better both the patient-related factors and drug administration techniques involved in Sugammadex-associated cardiovascular compromise to improve clinical decision-making for anesthesia providers.http://www.sciencedirect.com/science/article/pii/S221454192200030XSugammadexObesityGeneral anesthesiaAsystoleNeuromuscular blockade
spellingShingle Steven J. Lohmeier
David B. Powers
Sugammadex-associated asystole in young obese patient: Case report
Oral and Maxillofacial Surgery Cases
Sugammadex
Obesity
General anesthesia
Asystole
Neuromuscular blockade
title Sugammadex-associated asystole in young obese patient: Case report
title_full Sugammadex-associated asystole in young obese patient: Case report
title_fullStr Sugammadex-associated asystole in young obese patient: Case report
title_full_unstemmed Sugammadex-associated asystole in young obese patient: Case report
title_short Sugammadex-associated asystole in young obese patient: Case report
title_sort sugammadex associated asystole in young obese patient case report
topic Sugammadex
Obesity
General anesthesia
Asystole
Neuromuscular blockade
url http://www.sciencedirect.com/science/article/pii/S221454192200030X
work_keys_str_mv AT stevenjlohmeier sugammadexassociatedasystoleinyoungobesepatientcasereport
AT davidbpowers sugammadexassociatedasystoleinyoungobesepatientcasereport